Fresenius Medical Care Ag (FMS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access FMS Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Fresenius Medical Care Ag's cash-generating activities.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
0 0 0 (Dec 31 2024)
Operating Activities
Income1,334.22
Depreciation & amortization1,680.46
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Adjustments For Decrease IncreaseIn Other Assets231.72
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-326.85
Gain Loss On Sale Of Fixed Assets Right Of Use Assets Investments And Divestitures-
Adjustments For Sharebased Payments-
Adjustments For Finance Income Cost-
Adjustments For Decrease Increase In Trade And Other Receivables From Third Parties-
Adjustments For Decrease Increase In Inventories-
Adjustments For Increase Decrease In Trade Account Payable Related Parties-
Adjustments For Increase Decrease In Accounts Payable Provisions And Other Current And Non Current Liabilities-
Adjustments For Increase Decrease In Income Tax Payable-
Cash Inflow From Hedging-
Dividends Received Classified As Operating Activities-
Income Taxes Paid Refund Classified As Operating Activities-
Income taxes-30.48
Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method-203.13
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities8.27
Discontinued operations0.00
Net Cash flow from Operating Activities3,002.72
Investing Activities
Capital Expenditures0.00
Sale of Capital Items18.70
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Divestitures-
Other Cash Receipts From Sales Of Equity Or Debt Instruments Of Other Entities Classified As Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-1,147.85
Discontinued operations0.00
Net Cash Flow from Investing Activities-809.23
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-940.34
Long-term debt - repayments1,817.26
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-2,288.90
Conversion Of Stock Amount Converted-
Increase Decrease In Accounts Receivable Securitization Program-
Payments To Acquire Or Redeem Entitys Shares-
Proceeds From Contributions Of Noncontrolling Interests-
Increase Decrease In Cash And Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-1,571.59
Effect of exchange rate on cash flow-158.45
Discontinued operations0.00
Free Cash Flow3,021.42
Total Cash Flow463.44
4 historic quarters locked

Sign in to unlock the full Fresenius Medical Care Ag cash flow history.

About Fresenius Medical Care Ag Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-019005

Figures are derived from filed reports and may be restated. Historical data is subject to revision.